Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made, if any, of the per capita uptake of NICE approved medicines for treating Inflammatory Bowel Disease in their first year of launch, for medicines first marketed between 2014 and 2018.
No direct assessment has been made.